Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Global Blood Therapeutics Inc (GBT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Global Blood Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Global Blood Therapeutics Inc historical data, for real-time data please try another search
68.49 +0.00    +0.00%
04/10 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 68.47 - 68.49
Global Blood Therapeutics Inc 68.49 +0.00 +0.00%

Global Blood Therapeutics Inc Company Profile

 
Get an in-depth profile of Global Blood Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

457

Equity Type

ORD

Global Blood Therapeutics, Inc., a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat grievous blood-based disorders. The company offers Oxbryta tablets, an oral once-daily therapy for SCD. It also evaluates pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company develops its lead product candidate inclacumab, a human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises and resulting hospital admissions and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. Global Blood Therapeutics, Inc. was incorporated in 2011 and is based in South San Francisco, California with additional locations in Baar, Switzerland; Paris, France; Berlin, Germany; and London, United Kingdom. As of October 5, 2022, Global Blood Therapeutics, Inc. operates as a subsidiary of Pfizer Inc.

Contact Information

Address 400 East Jamie Court Suite 101
South San Francisco, 94080
United States
Phone 650 741 7700
Fax -
Web
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GBT Comments

Write your thoughts about Global Blood Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
José Catalá
José Catalá Aug 05, 2022 11:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
IS the market closed?
Adam Bn
Adam Bn Aug 03, 2021 7:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its 8/3/21 and this stock is sbout to rocket after dropping for over a year straight. Trade of the year
Libero Modesto
Libero Modesto Nov 05, 2020 4:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what's happening in after hours? any news?
Tevin Kidd
Tevin Kidd Nov 05, 2020 4:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This a GO
Wojciech Stefaniak
Wojciech Stefaniak Jun 15, 2020 10:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Worthless company?
Roberto Oriani
Roberto Oriani May 11, 2020 9:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://newsglobetoday.com/2020/05/11/huge-growth-potential-ahead-global-blood-therapeutics-inc-gbt-stock-and-graftech-international-ltd-eaf-stock/
Michelle Saint
Michelle Saint Nov 27, 2019 12:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
WOW GBT very successful sickle cell treatment
James Wills
James Wills Aug 02, 2019 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
70 is optimistic, but maybe 60...
Michelle Saint
Michelle Saint Aug 02, 2019 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At least $106
Episcopolian OptionTrader
Episcopolian1 Dec 15, 2017 2:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Looks like $35 is the IPO price. Must give some wriggle room to institutional investors.
PMontalban Marubozu
TOLEDOBullMarket Dec 11, 2017 3:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy ... 70$ next year
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email